NVNO
enVVeno Medical Corporation
NASDAQ · Healthcare · Medical - Devices · US
$11.75
+5.86%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- +31.0%
- EBIT
- +32.6%
- EPS
- +64.9%
- Free cash flow
- +14.7%
- Operating cash flow
- +14.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- +63.4%
- EPS
- +98.2%
Three-year CAGR
- Revenue
- —
- EBITDA
- +10.8%
- EBIT
- +12.3%
- Net income
- +10.8%
- EPS
- +97.9%
- Free cash flow
- +7.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026